Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is a widely available curative option for patients with sickle cell disease (SCD). Our original non-myeloablative haplo-HSCT trial employing post-transplant (PT) cyclophosphamide had a low incidence of GVHD but had high rejection ra...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Deepali K. Bhat, Purevdorj B. Olkhanud, Arunakumar Gangaplara, Fayaz Seifuddin, Mehdi Pirooznia, Angélique Biancotto, Giovanna Fantoni, Corinne Pittman, Berline Francis, Pradeep K. Dagur, Ankit Saxena, J. Philip McCoy, Ruth M. Pfeiffer, Courtney D. Fitzhugh
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	donor myeloid chimerism haploidentical HSCT Tregs IL-10 sickle cell disease early myeloid derived suppressor cells Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/24e70ed7cf154c4e8c2147f41d584da8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease

Ejemplares similares